Virtus ETF Advisers LLC Bio Xcel Therapeutics, Inc. Transaction History

Virtus ETF Advisers LLC

14 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2023 Nov 07, 2023	SELL	$2.49 - $11.85 $1,155 - $5,498	-464 Reduced 9.08%	4,646 $11,000
Q2 2023 Aug 14, 2023	SELL	$6.39 - $28.58 $1,207 - $5,401	-189 Reduced 3.57%	5,110 $34,000
Q1 2023 May 15, 2023	SELL	$17.7 - $33.24 $36,001 - $67,610	-2,034 Reduced 27.74%	5,299 $98,000
Q4 2022 Feb 14, 2023	SELL	$10.25 - $22.43 $41,328 - $90,437	-4,032 Reduced 35.48%	7,333 $157,000
Q3 2022 Nov 14, 2022	BUY	$11.19 - $17.89 $906 - $1,449	81 Added 0.72%	11,365 $134,000
Q2 2022 Aug 12, 2022	BUY	$9.03 - $21.55 $32,246 - $76,955	3,571 Added 46.3%	11,284 $149,000
Q1 2022 May 16, 2022	SELL	$15.0 - $22.83 $6,765 - $10,296	-451 Reduced 5.52%	7,713 $161,000
Q4 2021 Feb 14, 2022	BUY	$20.12 - $35.09 $52,613 - $91,760	2,615 Added 47.13%	8,164 $166,000
Q3 2021 Nov 15, 2021	SELL	$23.84 - $32.03 $6,722 - $9,032	-282 Reduced 4.84%	5,549 $168,000
Q2 2021 Aug 10, 2021	SELL	$29.06 - $38.83 $19,034 - $25,433	-655 Reduced 10.1%	5,831 $169,000
Q1 2021 May 17, 2021	BUY	$39.04 - $64.6 $4,762 - $7,881	122 Added 1.92%	6,486 $280,000
Q4 2020 Feb 12, 2021	SELL	$42.46 - $56.58 $5,095 - $6,789	-120 Reduced 1.85%	6,364 $294,000
Q3 2020 Nov 13, 2020	SELL	$37.44 - $64.63 $33,246 - $57,391	-888 Reduced 12.05%	6,484 $281,000
Q2 2020 Aug 05, 2020	BUY	$17.62 - $58.71 $129,894 - $432,810	7,372 New	7,372 $391,000

3.11M

22.2K

40.2K

Ticker BTAI
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 28,022,500
Market Cap $8.41M
Description
BioXcel Therapeutics, Inc. is a commercial-stage biopharmaceutical company utilizing artificial intelligence approaches to develop transformative medicines in neuroscience and immuno-oncology. The company's drug re-innovation approach leverages existing approved drugs and/or clinically validated product candidates together with big data and prop...

Get notified when there are updates to the investment portfolio of Virtus ETF Advisers LLC, based on Form 13F filings with the SEC.

Stay updated on Virtus ETF Advisers LLC with notifications on news.